HYPOPHARYNX CANCER
Clinical trials for HYPOPHARYNX CANCER explained in plain language.
Never miss a new study
Get alerted when new HYPOPHARYNX CANCER trials appear
Sign up with your email to follow new studies for HYPOPHARYNX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pill combo aims to tame recurrent head and neck cancer in rural patients
Disease control Recruiting nowThis study tests whether taking three oral drugs (methotrexate, erlotinib, and celecoxib) together is safe and practical for patients with head and neck cancer that has come back or spread. It enrolls 25 adults in the rural Midwest. The goal is to see if this all-pill regimen can…
Matched conditions: HYPOPHARYNX CANCER
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 06:18 UTC
-
New drug combo aims to shrink Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis study tests whether combining two drugs, sacituzumab govitecan and cetuximab, can shrink tumors in people with advanced head and neck cancer that has returned or spread after initial treatment. About 40 adults whose cancer worsened after first-line therapy will receive the c…
Matched conditions: HYPOPHARYNX CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Could less radiation plus a vitamin a drug beat head and neck cancer?
Disease control Recruiting nowThis study tests two ideas for people with certain head and neck cancers: using a smaller radiation area to reduce side effects, and adding a drug called ATRA (a form of vitamin A) to help control the disease. About 460 adults will be randomly assigned to standard or smaller radi…
Matched conditions: HYPOPHARYNX CANCER
Phase: PHASE3 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated May 13, 2026 15:59 UTC